Research and Markets: Global Hemophilia A Market 2015-2019
By Business Wire News
By Business Wire News
Research and Markets (http://www.researchandmarkets.com/research/vz3vnl/global_hemophilia) has announced the addition of the “Global Hemophilia A Market 2015-2019” report to their offering.
The global hemophilia A drugs market to grow at a CAGR of 6.25% over the period 2014-2019.
The report, Global Hemophilia A Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, and Americas; it also covers the landscape of the global hemophilia A drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
The report covers the current scenario and the growth prospects of the global hemophilia A drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment and prevention of hemophilia A. In this report, the market is also segmented based on the type of therapy.
There are new technological advancements in terms of drug manufacturing, development, and delivery. These advances has led to the development of recombinant products. For instance, animal or human plasma proteins are not used to manufacture NovoSeven, thereby decreasing the risk of infection. The use of Fc-fusion technology has increased the half-life of Eloctate in blood, thereby improving drug action.
According to the report, the development of new hemophilia A therapeutics with prolonged action is prompting market growth. Vendors are developing a number of products, which are in the pipeline stage. The anticipated approval of these products will impact the growth of the market during the forecast period.
Further, the report states that the high cost of treatment leads to the discontinuation of therapy, thereby hampering market growth.
– Baxter International
– CSL Behring
– Novo Nordisk
Other prominent vendors
– Alnylam Pharmaceuticals
– Amarna Therapeutics
– Biogen Idec
– Catalyst Biosciences
– Dimension Therapeutics
– Dong-A Socio
– Emergent BioSolutions
– Inspiration Biopharmaceuticals
– Kedrion Biopharma
– OPKO Health
– rEVO Biologics
– Sangamo BioSciences
– Spark Therapeutics
For more information visit http://www.researchandmarkets.com/research/vz3vnl/global_hemophilia
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Hematology